Researchers discover key mutation in acute myeloid leukemia – 1
Narrator: This is NIH Health Matters. I’m Joe Balintfy. Researchers have discovered mutations in a particular gene that affect the treatment prognosis for some patients with acute myeloid leukemia or AML. AML is an aggressive blood cancer.
Ley: It is a very bad disease to get.
Narrator: That’s Dr. Tim Ley at the Washington University School of Medicine in St. Louis. He says there are 13,000 new AML patients in America annually.
Ley: 13,000 news cases a year and 9,000 deaths.
Narrator: He explains that in this disease, the cancer cells or tumors crowd out the normal cells in bone marrow, where the elements of blood are made in the human body. For more on AML visit www.cancer.gov. Health Matters is produced by the National Institutes of Health, part of the U.S. Department of Health and Human Services.
About NIH Radio
NIH Radio offers free audio news programs from the National Institutes of Health, your reliable source for health information.
All NIH Radio content is in the public domain and can be used without charge or restriction provided that it is not used to misrepresent our agency nor used to suggest we endorse any private organization, product, or service.
NIH Radio is a service of the Office of Communications & Public Liaison.